Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial (Annals of the Rheumatic Diseases, 2020)

(untitled) - Baraliakos, X; Gossec, L; Pournara, E; Jeka, S; Varela, AM; D’Angelo, S; Schulz, B; Rissler, M; Nagar, K; Perella, C; Coates, LC